Sequist, L. V.; Anderson, I.; Bauer, T. M.; Demars, N.; Felip, E.; Frost, N.; Harb, W.; Horn, L.; Huber, R. M.; Kudla, A. J.; Lee, J.; Mathews, S.; Mehra, R.; Nieva, J.; Perol, M.; Shepherd, F.; Spira, A. and Czibere, A.
(2016):
A phase 2 study of seribantumab (MM-121) in combination with docetaxel or pemetrexed versus docetaxel or pemetrexed alone in patients with heregulin positive (HRG plus ), locally advanced or metastatic non-small cell lung cancer (NSCLC).
In: Annals of Oncology, Vol. 27
Item Type: | Journal article |
---|---|
Faculties: | Medicine |
Subjects: | 600 Technology > 610 Medicine and health |
ISSN: | 0923-7534 |
Language: | English |
Item ID: | 46066 |
Date Deposited: | 27. Apr 2018, 08:10 |
Last Modified: | 04. Nov 2020, 13:22 |